Client Request A leading global biopharmaceutical company approached CSI with an urgent need for the Fluarix QIV Southern Hemisphere Vaccine 2025. The requirements included: Quantity: 10,000 doses Delivery Date: As soon as possible (urgent) Delivery Location: Singapore Batch Preference: Multiple lots acceptable if necessary The Challenge The client was let down by a supplier in Brazil and needed to secure alternative stock at the last minute. Complicating matters, the Fluarix

CSI’s Strategic Approach to Mitigating Clinical Trial Supply Disruption Recent developments in U.S. trade policy are shaking up supply chains, not just within the United States but worldwide. With the re-introduction of Trump-era tariffs on key goods, companies engaged in clinical research must rethink their sourcing and logistics strategies. Clinical Services International (CSI) is proactively addressing these challenges to support our clients amid this uncertain climate. Wh

We’re proud to share that CSI is now fully registered and qualified with SAM.gov and BARDA , enabling us to support U.S....

A Global Pharmaceutical Sponsor’s Challenge A global pharmaceutical sponsor conducting a Phase III clinical trial needed Semaglutide, a GLP-1 receptor agonist, as a comparator drug. The study spanned multiple regions, including North America, Europe, and Asia-Pacific. This required a consistent and compliant supply of the drug across various regulatory landscapes. The sponsor needed a reliable partner to source Semaglutide efficiently while ensuring batch consistency, Certifi

CSI attended the Global Clinical Supplies Group (GCSG) US Conference in San Antonio, Texas, April 27th-30th. The event brought together clinical supply professionals from around the world to discuss industry trends, challenges and strategies for your clinical trial pipeline. CSI’s Managing Director, Vanessa Dekou, hosted a successful and sell-out workshop at GCSG US, to share over 25 years’ worth of expert insights on the complexities of comparator sourcing strategies. If yo

Exciting news! CSI will be exhibiting at GCSG Asia Pacific 2024 this week, on March 12-13 in Seoul! Visit us at Table 7 to learn how our expert clinical supply solutions can streamline your global trial supplies. Let’s connect and explore how CSI’s direct manufacturer relationships, scientific expertise and sustainable sourcing can support your study needs. See you there! 👋

A Leading Biotech Client's Challenge A leading biotech client approached CSI to assist in sourcing the comparator drug Lucentis for a Phase II ophthalmology clinical trial. This project demanded precise planning and timely execution. It was crucial to ensure an uninterrupted supply across multiple global sites. The client prioritized batch consistency and Certificates of Analysis (CoA) for all supplies. Understanding the Challenges The biotech company faced several hurdles in

We’re excited to announce that Stephan Muetze, Director of Project Management, and Yasmine Clemson, Project Management and Marketing Associate, will be representing CSI at Clinical Trial Supply (CTS) Barcelona on 25th and 26th February. We don’t just support clinical trials—we inspire change, drive progress, and celebrate the power of diversity. Schedule a meeting here: www.csint.com/contact-us

Which Trends Will Shape Clinical Trial Supplies in 2025? The clinical trial supply industry is rapidly evolving. This change is driven by...